Personal care segment benefits from strength in preservatives
Swiss specialty ingredients and pharma and biotech supplier Lonza has reported that its business performance has remained on track as anticipated in the third quarter of 2013. Lonza's specialty ingredients business, which includes its personal care segment, delivered a good performance. Personal care specifically experienced continued strength in preservatives, especially in new multi-national customer product introductions, said the company.
Lonza predicts that overall results, combined with its on track reorganisation and improvement projects, will mean overall 2013 CORE EBIT growth of approximately 10%, with revenues remaining on the previous year's levels and CAPEX for 2013 remaining just below CHF250m.